Literature DB >> 22313378

Critical appraisal of maxillary swing approach for nasopharyngeal carcinoma.

Jimmy Yu Wai Chan1, William Ignace Wei.   

Abstract

BACKGROUND: The aim of the current study was to report results of salvage nasopharyngectomy using the maxillary swing approach for persistent or recurrent nasopharyngeal carcinoma after primary treatment.
METHODS: Between 1989 and 2011, Nasopharyngectomies were performed in 312 patients. Data were composed of retrospective review of records of the first 72 patients followed by a prospective collection of data for the remaining patients.
RESULTS: Among the patients, 41 (13.1%) had persistent tumours and 271 (86.9%) had recurrent disease. Curative resection was achieved in 248 (79.5%) patients. All patients survived the operations. The median follow up duration was 34 months. The overall 5-year actuarial local tumour control was 74% and the overall 5-year disease-free survival was 56%. Those with negative resection margins on frozen section and tumour size less than 1.5 cm in diameter had significantly better local tumour control in the nasopharynx as well as disease-free survival.
CONCLUSIONS: Maxillary swing nasopharyngectomy is an effective salvage procedure for small, persistent or recurrent tumour in the nasopharynx after primary therapy.

Entities:  

Mesh:

Year:  2012        PMID: 22313378     DOI: 10.1517/14728222.2011.637920

Source DB:  PubMed          Journal:  Expert Opin Ther Targets        ISSN: 1472-8222            Impact factor:   6.902


  7 in total

1.  Surgical salvage of recurrent nasopharyngeal carcinoma.

Authors:  Jimmy Yu Wai Chan
Journal:  Curr Oncol Rep       Date:  2015-03       Impact factor: 5.075

2.  Nasopharynx access by minimally invasive transoral robotic surgery: anatomical study.

Authors:  Amine Harichane; Dorian Chauvet; Stéphane Hans
Journal:  J Robot Surg       Date:  2018-03-16

3.  Clinical outcomes of residual or recurrent nasopharyngeal carcinoma treated with endoscopic nasopharyngectomy plus chemoradiotherapy or with chemoradiotherapy alone: a retrospective study.

Authors:  Jingjin Weng; Jiazhang Wei; Jinyuan Si; Yangda Qin; Min Li; Fei Liu; Yongfeng Si; Jiping Su
Journal:  PeerJ       Date:  2017-10-09       Impact factor: 2.984

Review 4.  Recommendations for surgical management of recurrent nasopharyngeal carcinoma during COVID-19 pandemic.

Authors:  Velda Ling Yu Chow; Jimmy Yu Wai Chan; Stanley Thian Sze Wong; William Ignace Wei
Journal:  Laryngoscope Investig Otolaryngol       Date:  2020-06-13

Review 5.  Recurrent Nasopharyngeal Cancer: Critical Review of Local Treatment Options Including Recommendations during the COVID-19 Pandemic.

Authors:  Michaela Svajdova; Marian Sicak; Pavol Dubinsky; Marek Slavik; Pavel Slampa; Tomas Kazda
Journal:  Cancers (Basel)       Date:  2020-11-25       Impact factor: 6.639

6.  Clinical Characteristics and Predictive Outcomes of Recurrent Nasopharyngeal Carcinoma-A Lingering Pitfall of the Long Latency.

Authors:  Yung-Hsuan Chen; Sheng-Dean Luo; Shao-Chun Wu; Ching-Nung Wu; Tai-Jan Chiu; Yu-Ming Wang; Yao-Hsu Yang; Wei-Chih Chen
Journal:  Cancers (Basel)       Date:  2022-08-04       Impact factor: 6.575

Review 7.  Treatment of Recurrent Nasopharyngeal Carcinoma: A Sequential Challenge.

Authors:  Zhouying Peng; Yumin Wang; Ruohao Fan; Kelei Gao; Shumin Xie; Fengjun Wang; Junyi Zhang; Hua Zhang; Yuxiang He; Zhihai Xie; Weihong Jiang
Journal:  Cancers (Basel)       Date:  2022-08-25       Impact factor: 6.575

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.